Two Sigma Investments’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,553
Closed -$140K 3004
2022
Q3
$140K Buy
+2,553
New +$140K ﹤0.01% 2184
2020
Q2
Sell
-1,369
Closed -$92K 3367
2020
Q1
$92K Sell
1,369
-641
-32% -$64.6K ﹤0.01% 2856
2019
Q4
$278K Buy
+2,010
New +$261K ﹤0.01% 3239
2019
Q1
Sell
-6,946
Closed -$646K 3361
2018
Q4
$646K Buy
+6,946
New +$992K ﹤0.01% 1939
2018
Q3
Sell
-2,193
Closed -$921K 3475
2018
Q2
$921K Buy
+2,193
New +$739K ﹤0.01% 2205

Other funds holding OPTN

Two Sigma Investments's OPTN Position: Q4 2022 in Review

Two Sigma Investments sold out of OptiNose (OPTN) in Q4 2022, closing a stake of 2,553 shares — an estimated $140K sold.

Two Sigma Investments first reported a position in OPTN in Q2 2018 and held it in 5 quarters. The position peaked at $921K in Q2 2018. 55 funds tracked by Wall St. Rank hold OPTN as of Q4 2022.

  • Two Sigma Investments reported no remaining OptiNose position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Investments sold 2,553 OptiNose shares in Q4 2022, an estimated $140K.
  • Two Sigma Investments first reported a position in OptiNose in Q2 2018 and held it in 5 quarters.
  • Two Sigma Investments's OptiNose position peaked at $921K in Q2 2018.
  • 55 funds tracked by Wall St. Rank held OptiNose as of Q4 2022.

Based on Two Sigma Investments's 13F filing for Q4 2022, filed 14 Feb 2023.